How Waterproof Mortar Additives Improve Mortar Performance and Durability
15 September, 2026
In recent years, ophthalmic treatments have advanced significantly, yet one persistent challenge remains: ensuring that medications applied to the eye are efficiently absorbed and retained long enough to exert therapeutic effects. Among the array of excipients used to improve the performance of eye drops, Hydroxypropyl Methylcellulose (HPMC) stands out for its unique ability to enhance both absorption and patient comfort. This article explores how HPMC plays a critical role in ophthalmic formulations, especially in boosting drug efficacy and extending residence time on the ocular surface.
The eye, while delicate, is equipped with powerful natural defenses. Its blinking mechanism, tear production, and drainage system are all designed to remove foreign substances rapidly—including medications. As a result, traditional eye drops often face difficulties in achieving effective therapeutic concentrations.
Upon administration, a typical eye drop remains on the ocular surface for only 2 to 3 minutes before it is washed away. Less than 5% of the active drug typically penetrates the corneal barrier. This means frequent application is often necessary, which can be inconvenient and lead to poor patient compliance.
Here’s a quick comparison that highlights the challenges:
| Parameter | Without HPMC | With HPMC |
|---|---|---|
| Retention Time | 2–3 minutes | Up to 10–15 minutes |
| Drug Bioavailability | <5% | 5%–10% (improved) |
| Tear Film Stability | Poor | Enhanced |
| Patient Comfort | Variable | Improved Lubrication |
The figures above are indicative and may vary depending on the drug and formulation. However, the inclusion of HPMC consistently demonstrates better outcomes in both lab and clinical settings.
Hydroxypropyl Methylcellulose is a semi-synthetic, inert polymer derived from cellulose. It is widely used in pharmaceuticals as a binder, film former, and viscosity enhancer. In ophthalmology, its water-soluble, non-ionic properties make it an ideal candidate for enhancing drug delivery.
Key features that make HPMC valuable in eye care formulations include:
By increasing the viscosity of eye drop solutions, HPMC slows the drainage of the drug from the eye, effectively giving the active ingredients more time to be absorbed. This directly translates into improved bioavailability without increasing the dosage.
HPMC is not only used in general eye drops but also in more specialized formulations, such as artificial tears, antibiotic eye drops, and treatments for chronic conditions like glaucoma or allergic conjunctivitis. Its versatility allows pharmaceutical scientists to develop targeted therapies that are both effective and well tolerated.
Let’s look at several examples of how HPMC functions in practice:
Artificial Tears for Dry Eye Syndrome
Dry eye disease affects millions globally, particularly among older adults and individuals who spend long hours in front of screens. Formulations containing HPMC mimic the natural tear film and offer longer-lasting relief compared to water-based eye drops. Its lubricating effect reduces the gritty or burning sensation and helps repair damaged epithelial cells on the cornea.
Antibiotic and Anti-inflammatory Drops
Many antibiotics and corticosteroids suffer from low bioavailability due to their hydrophobic nature. By formulating them with HPMC, the drugs stay longer on the eye surface, which improves therapeutic results and reduces the frequency of application.
Ophthalmic Surgery and Post-Operative Care
After procedures like cataract surgery or LASIK, eyes are particularly vulnerable. HPMC-based lubricants and healing agents provide a protective layer that prevents desiccation and irritation while facilitating faster recovery.
Allergy Relief and Antihistamine Formulations
Seasonal or chronic allergic conjunctivitis can cause itching, redness, and tearing. HPMC acts as a barrier, reducing exposure to allergens and helping antihistamines act more effectively by maintaining prolonged contact with the ocular tissues.
The inclusion of HPMC provides multiple advantages not only for pharmaceutical scientists but also for the patients who rely on ophthalmic therapies daily. Below is a structured breakdown:
Moreover, HPMC-based formulations have demonstrated excellent shelf stability, making them suitable for commercial-scale production and global distribution, even in regions with varying climatic conditions.
As the demand for more effective and patient-friendly ophthalmic treatments grows, pharmaceutical companies are turning to proven excipients like HPMC to enhance product performance. In parallel, regulatory bodies such as the FDA and EMA have recognized the safety profile of HPMC, further reinforcing its reliability.
Emerging trends in the field include:
HPMC’s adaptability positions it well to support next-generation ocular therapies, whether for treating infections, reducing inflammation, or managing chronic visual conditions.
Q1: Is HPMC safe for long-term use in the eyes?
Yes. HPMC is widely regarded as non-toxic and non-irritating. It is approved by health authorities globally and used in both over-the-counter and prescription products.
Q2: Does HPMC blur vision after application?
HPMC increases viscosity, which may cause slight blurriness immediately after application. However, this is usually transient and considered acceptable in exchange for prolonged relief.
Q3: Can HPMC be used in preservative-free formulations?
Absolutely. Its excellent stability and compatibility make it a popular choice for preservative-free or single-use vial systems.
Q4: Is HPMC suitable for sensitive eyes or contact lens users?
Yes. HPMC-based solutions are often recommended for users with sensitive eyes or those who wear contact lenses, as they mimic natural tears and provide gentle lubrication.
While the active pharmaceutical ingredient (API) often gets the spotlight, the role of excipients like HPMC is equally critical in ensuring a formulation’s success. From improving retention time to enhancing patient comfort, HPMC has become a cornerstone in modern ophthalmic formulations.
With over 20 years of experience, Meska Joinway is a trusted supplier of high-quality pharmaceutical excipients, including HPMC tailored for ophthalmic use. By supporting pharmaceutical manufacturers with reliable, consistent, and compliant materials, Meska Joinway plays a quiet yet essential role in advancing eye care across the globe.
Get in Touch: sales@joinwaypharm.cn | www.meskajoinway.com
HPMC and L-HPC manufacturer
22 years of production and sales experience
CEP-certified products meet FDA and GMP regulations
